{"CYP3A5 Diplotype": "Coded Diplotype/Phenotype Summarya", "*1/*1": "CYP3A5 Normal Metabolizerc", "*1/*2": "CYP3A5 Possible Intermediate Metabolizer", "*1/*3": "CYP3A5 Intermediate Metabolizer", "*1/*4": "CYP3A5 Possible Intermediate Metabolizer", "*1/*5": "CYP3A5 Possible Intermediate Metabolizer", "*1/*6": "CYP3A5 Intermediate Metabolizer", "*1/*7": "CYP3A5 Intermediate Metabolizer", "*1/*8": "CYP3A5 Possible Intermediate Metabolizer", "*1/*9": "CYP3A5 Possible Intermediate Metabolizer", "*2/*2": "Indeterminate", "*2/*3": "Indeterminate", "*2/*4": "Indeterminate", "*2/*5": "Indeterminate", "*2/*6": "Indeterminate", "*2/*7": "Indeterminate", "*2/*8": "Indeterminate", "*2/*9": "Indeterminate", "*3/*3": "CYP3A5 Poor Metabolizer", "*3/*4": "Indeterminate", "*3/*5": "Indeterminate", "*3/*6": "CYP3A5 Poor Metabolizer", "*3/*7": "CYP3A5 Poor Metabolizer", "*3/*8": "Indeterminate", "*3/*9": "Indeterminate", "*4/*4": "Indeterminate", "*4/*5": "Indeterminate", "*4/*6": "Indeterminate", "*4/*7": "Indeterminate", "*4/*8": "Indeterminate", "*4/*9": "Indeterminate", "*5/*5": "Indeterminate", "*5/*6": "Indeterminate", "*5/*7": "Indeterminate", "*5/*8": "Indeterminate", "*5/*9": "Indeterminate", "*6/*6": "CYP3A5 Poor Metabolizer", "*6/*7": "CYP3A5 Poor Metabolizer", "*6/*8": "Indeterminate", "*6/*9": "Indeterminate", "*7/*7": "CYP3A5 Poor metabolizer", "*7/*8": "Indeterminate", "*7/*9": "Indeterminate", "*8/*8": "Indeterminate", "*8/*9": "Indeterminate", "*9/*9": "Indeterminate", "aThe coded diplotype/phenotype summary is used to store an interpretation of the test result.  This is a design decision that may differ among sites.": "", "bFor this example, a priority result is defined as a genetic test result that results in a change in drug, drug dose, or drug monitoring.": "", "cThe term \"CYP3A5 Extensive Metabolizer\" from the guideline has been replaced with \"CYP3A5 Normal Metabolizer\" per the CPIC Standardization Project.": ""}